Your good ideas will finally be heard! We are the engine for fast and pragmatic implementation for the benefit of our patients.
We are looking for graduates for our Controlling/Finance starter program at our Helios Klinikum Berlin-Buch site as soon as possible.
The program lasts 2 years, after which a permanent position is sought.
Optimal training for a qualified, possibly also managerial position in the area of finance/controlling at the Helios clinics in the eastern region
An above-average degree from a university or university of cooperative education with a business administration or comparable focus is required, ideally with a focus on accounting or controlling
Reasonable remuneration
Helios is the leading hospital operator in Europe. Collegial and interdisciplinary cooperation and the rapid implementation of innovations guarantee our patients the best possible care. This creates a unique space for your knowledge, talents, ideas and future plans.
Please send us your application documents online via our application portal, stating your earliest possible starting date.
Your application is just a click away!
Equal opportunities in the workplace are important to us. That is why we expressly encourage people with disabilities of all gender identities and backgrounds to apply.
Mr. Michael Lasslop
Head of Controlling
030 9401-57894
Michael.lasslop@helios-gesundheit.de
Helios Verwaltung Ost GmbH
Helios Clinic Berlin-Buch
Schwanebecker Chaussee 50
13125 Berlin-Buch
Please submit your application in German. As long as the job ad is online, you can apply quickly and easily.
At Fresenius all job applicants are welcome – regardless of gender, age, origin, nationality, religion, disability, sexual identity and orientation, or any other personal characteristics.
All terms used in this job advertisement to denote persons refer to all genders equally (male, female, diverse).
When it’s not just a job, but your calling. When you have an impact on people’s lives every day. When you can’t imagine doing something else. Then you know it’s Fresenius.